Krystal Biotech (KRYS) Short Interest Ratio & Short Volume → Does this chart look familiar? (From InvestorPlace) (Ad) Free KRYS Stock Alerts $154.82 +0.06 (+0.04%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Krystal Biotech Short Interest DataCurrent Short Volume2,590,000 sharesPrevious Short Volume2,450,000 sharesChange Vs. Previous Month+5.71%Dollar Volume Sold Short$396.58 millionShort Interest Ratio / Days to Cover6.6Last Record DateApril 30, 2024Outstanding Shares28,560,000 sharesPercentage of Shares Shorted9.07%Today's Trading Volume192,160 sharesAverage Trading Volume358,305 sharesToday's Volume Vs. Average54% Short Selling Krystal Biotech ? Sign up to receive the latest short interest report for Krystal Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKRYS Short Interest Over TimeKRYS Days to Cover Over TimeKRYS Percentage of Float Shorted Over Time Ad InvestorPlaceMillionaire investor and Republican donor makes surprising election predictionFind out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs Krystal Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,590,000 shares $396.58 million +5.7%N/A6.6 $153.12 4/15/20242,450,000 shares $415.89 million +12.9%N/A6.2 $169.75 3/31/20242,170,000 shares $386.11 million -3.1%N/A5.5 $177.93 3/15/20242,240,000 shares $387.48 million -10.8%N/A5.8 $172.98 2/29/20242,510,000 shares $400.27 million +1.6%N/A6.5 $159.47 2/15/20242,470,000 shares $280.05 million +21.7%N/A7.3 $113.38 Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,030,000 shares $225.84 million +3.1%N/A6.6 $111.25 1/15/20241,970,000 shares $252.87 million -9.2%N/A6.3 $128.36 12/31/20232,170,000 shares $269.21 million +11.3%N/A7.1 $124.06 12/15/20231,950,000 shares $225.73 million -8.0%N/A6.4 $115.76 11/30/20232,120,000 shares $220.97 million +2.4%N/A6.8 $104.23 11/15/20232,070,000 shares $206.09 million -1.4%N/A6.8 $99.56 10/31/20232,100,000 shares $245.43 million +7.1%N/A7.1 $116.87 10/15/20231,960,000 shares $223.01 million -0.5%N/A7.4 $113.78 9/30/20231,970,000 shares $228.52 million +23.9%N/A7.4 $116.00 9/15/20231,590,000 shares $191.07 million +6.0%N/A5.9 $120.17 8/31/20231,500,000 shares $186.72 million -2.6%N/A5.7 $124.48 8/15/20231,540,000 shares $187.82 million +15.8%N/A5.3 $121.96 7/31/20231,330,000 shares $171.70 million -7.6%N/A4.1 $129.10 7/15/20231,440,000 shares $181.83 million +6.7%6.8%4.7 $126.27 6/30/20231,350,000 shares $158.49 million +3.1%6.4%4.5 $117.40 6/15/20231,310,000 shares $163.37 million +10.1%6.2%4.3 $124.71 5/31/20231,190,000 shares $140.24 million +3.5%5.6%4.3 $117.85 5/15/20231,150,000 shares $103.56 million -0.9%5.5%4.4 $90.05 4/30/20231,160,000 shares $97.44 million -7.2%5.5%5.7 $84.00 4/15/20231,250,000 shares $107.98 million +4.2%6.0%6.4 $86.38 3/31/20231,200,000 shares $96.07 million +5.3%5.8%5.9 $80.06 3/15/20231,140,000 shares $83.80 million -4.2%5.5%5.9 $73.51 2/28/20231,190,000 shares $97.47 million +6.3%5.7%6.3 $81.91 2/15/20231,120,000 shares $82.33 million +6.7%5.4%6.5 $73.51 1/31/20231,050,000 shares $87.28 million -7.1%5.1%6.1 $83.12 1/15/20231,130,000 shares $93.73 million +14.4%5.4%6.5 $82.95 12/30/2022988,100 shares $78.28 million -10.2%4.8%5.9 $79.22 12/15/20221,100,000 shares $86.24 million -9.1%5.3%6.9 $78.40 11/30/20221,210,000 shares $94.07 million -3.2%5.9%7.8 $77.74 11/15/20221,250,000 shares $96.51 million -4.6%6.1%7.7 $77.21 10/31/20221,310,000 shares $100.22 million +3.2%6.4%7.9 $76.50 10/15/20221,270,000 shares $83.83 million -3.1%6.2%7.6 $66.01 9/30/20221,310,000 shares $91.31 million +7.4%6.4%7.9 $69.70 9/15/20221,220,000 shares $86.97 million -4.7%6.3%7.3 $71.29What’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. KRYS Short Interest - Frequently Asked Questions What is Krystal Biotech's current short interest? Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,590,000 shares of KRYS short. Learn More on Krystal Biotech's current short interest. What is a good short interest ratio for Krystal Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRYS shares currently have a short interest ratio of 7.0. Learn More on Krystal Biotech's short interest ratio. Which institutional investors are shorting Krystal Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Krystal Biotech: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Krystal Biotech's short interest increasing or decreasing? Krystal Biotech saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,590,000 shares, an increase of 5.7% from the previous total of 2,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Krystal Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Krystal Biotech: CRISPR Therapeutics AG (17.18%), Immunovant, Inc. (14.80%), Halozyme Therapeutics, Inc. (6.69%), Iovance Biotherapeutics, Inc. (22.64%), ImmunityBio, Inc. (40.08%), SpringWorks Therapeutics, Inc. (13.51%), Immunocore Holdings plc (9.37%), Arcellx, Inc. (8.89%), Exelixis, Inc. (3.35%), Revolution Medicines, Inc. (7.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Krystal Biotech stock? Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. KRYS shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Krystal Biotech? A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further. How often is Krystal Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CRSP Short Interest Data IMVT Short Interest Data HALO Short Interest Data IOVA Short Interest Data IBRX Short Interest Data SWTX Short Interest Data IMCR Short Interest Data ACLX Short Interest Data EXEL Short Interest Data RVMD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRYS) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsGold ManiaStansberry Research